-
Mashup Score: 0Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years - 6 month(s) ago
Background The association between the onset of type 2 diabetes (T2D) and atrial fibrillation (AF) risk in individuals with impaired glucose tolerance (IGT) remains unclear. This study aimed to inv…
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0ADVENT trial: ¿el campo pulsado viene para quedarse? - Sociedad Española de Cardiología - 6 month(s) ago
Estudio aleatorizado que compara los resultados de la ablación mediante campo pulsado frente al uso de sistemas térmicos en pacientes con FA paroxística.
Source: secardiologia.esCategories: Cardiologists1, Latest HeadlinesTweet
-
Mashup Score: 0
September 26, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascular diseases, founded by Blackstone Life Sciences, announced today that primary data from the AZALEA-TIMI 71study of patients with atrial fibrillation at moderate-to-high risk of stroke has been selected for a Late Breaking session at the American Heart Association Scientific Sessions 2023, being held November 11-13 in Philadelphia. This news comes just days after it was announced that the AZALEA-TIMI 71 study was stopped early by the independent Data Monitoring Committee (DMC) due to an overwhelming greater-than-anticipated reduction in major and clinically relevant non-major bleeds in abelacimab compared to rivaroxaban and a benefit/risk profile also favoring abelacimab. “The substantial reduction in bleeding with the monthly administered, dual-acting Factor XI/XIa inhibitor abelacimab compared to a standard-of-care anticoagulant represents an enormous potential a
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Histological validation of atrial structural remodelling in patients with atrial fibrillation - 6 month(s) ago
AbstractBackground and Aims. This study aimed to histologically validate atrial structural remodelling associated with atrial fibrillation.Methods and results.
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Atrial Fibrillation Ablation Improves Outcomes in Patients with End-stage Heart Failure - 7 month(s) ago
August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical therapy in patients with end-stage heart failure, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.1 Patients with end-stage heart failure eligible for heart transplantation have been excluded from major trials, leaving them with no recommendations or evidence for the optimal treatment of atrial fibrillation and advanced heart failure. There is uncertainty around the application of guidelines in this group2,3 and many novel advances in heart failure therapy are withheld in clinical practice. The CASTLE-HTx trial tested whether atrial fibrillation ablation is superior to medical therapy concerning mortality and need for urgent transplantation or LVAD implantation.4 The trial was conducted at the Heart and Diabetes Center North Rhine-Westphalia (NRW)
Source: www.dicardiology.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure - 7 month(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Are Fish Oils on the Hook for AF Risk? - 7 month(s) ago
Some studies of fish oil supplements have shown a higher risk for atrial fibrillation with marine omega-3 fatty acids. Is it real? What are the implications for patients taking these capsules?
Source: www.medscape.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Are #FishOils on the Hook for AF Risk? https://t.co/jRUgn48SL7 via @medscape #AtrialFibrillation #CVD #ASCVD Interesting, insightful, and important assessment, but @drjohnm has avoided possible benefits of #fishoil on other aspects of human health, e.g. #NervousSystem. #Brain… https://t.co/h8WriCh8jF
-
-
Mashup Score: 0Join Us For a Special Evening with Kareem Abdul-Jabbar - 8 month(s) ago
Join Us For a Special Evening with Basketball Legend Kareem Abdul-Jabbar
Source: www.stopafib.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Levels of omega-3 fatty acids in diet not linked to elevated risk for atrial fibrillation - 8 month(s) ago
Levels of omega-3 fatty acids, primarily from diet, were not related to risk for incident atrial fibrillation, according to a meta-analysis published in the Journal of the American College of Cardiology.The findings contrast with results of trials of omega-3 fatty acid supplementation, which found omega-3 fatty acid supplementation was associated with elevated risk for AF.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Levels of omega-3 fatty acids in diet not linked to elevated risk for atrial fibrillation - 8 month(s) ago
Levels of omega-3 fatty acids, primarily from diet, were not related to risk for incident atrial fibrillation, according to a meta-analysis published in the Journal of the American College of Cardiology.The findings contrast with results of trials of omega-3 fatty acid supplementation, which found omega-3 fatty acid supplementation was associated with elevated risk for AF.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
In this new study, @DahaiYuhEpi and colleagues explore the link between the onset of #Type2Diabetes and #AtrialFibrillation risk in individuals with impaired glucose tolerance. Findings reveal a potential mediating effect. #AHAJournals https://t.co/hKeeZLWObT https://t.co/gMQ36V7onO